ArticleJournal of the American College of Surgeons2021
Impact of the COVID-19 Pandemic on Lung Cancer Screening Program and Subsequent Lung Cancer.
Article in Journal of the American College of Surgeons, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
76 citing papers in PubMed.
- Impacts of a Public Health Emergency on Cancer Testing Rates, Follow-up, and Cancer Diagnosis: An Evaluation of the COVID-19 Pandemic.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026Article
- COVID-19 Vaccination and Pulmonary Nodules: A Narrative Review of Causality, Detection Bias and Thoracic Imaging Pitfalls.Vaccines · 2026Review
- Impact of the COVID-19 Pandemic on Lung Cancer Screening and Diagnosis: A Systematic Review.Cancers · 2026Review
- Enhancing lung cancer screening through 'saved by the scan': insights from a multipronged public service advertising campaign.BMC public health · 2026Article
- Disruption of Radiological Surveillance Following a Global Health Crisis in Resected Lung Cancer.Thoracic cancer · 2026Observational
- Impact of the COVID-19 pandemic on lung cancer screening utilization and outcome: a health examination center retrospective study.Annals of medicine · 2025Article
- Modeling Reporting Delay in Cancer Incidence Counts in the Evolving US and Canadian Population-Based Cancer Registry Environment.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025Article
- The COVID-19 pandemic increased the incidence of newly diagnosed cancers: evidence from a large cohort study in Southern Italy.BMC medicine · 2025Article
- Effects of the COVID-19 pandemic on surgical treatment for thoracic malignant tumor cases in Japan: a national clinical database analysis.Surgery today · 2025Article
- Patient-clinician discussions on lung cancer screening in the United States before and after 2021 guidelines.Translational behavioral medicine · 2025Article
- Artificial Intelligence in Cancer Diagnosis: A Game-changer in Healthcare.Current pharmaceutical biotechnology · 2025Review
- Spatiotemporal disparities in the diagnosis, treatment, and mortality of respiratory tract cancers in Brazil.PloS one · 2025Article
- Effect of the COVID-19 pandemic on colorectal cancer screening in two university-affiliated health care systems.PloS one · 2025Article
- Disruptions in Lung Cancer Detection During COVID-19.Cancers · 2024Article
- Brief Report: Understanding Program-Level Impact of COVID-19 in Lung Cancer Screening Programs in the United States.JTO clinical and research reports · 2024Article
- The Effect of COVID-19 on Lung Cancer Screening.Cureus · 2024Article
- An assessment of the association between patient characteristics and timely lung cancer treatment.Cancer causes & control : CCC · 2024Article
- Preventive Service Usage and New Chronic Disease Diagnoses: Using PCORnet Data to Identify Emerging Trends, United States, 2018-2022.Preventing chronic disease · 2024Article
- Comparison of transbronchial biopsy techniques using needle and forceps biopsies in lung cancer for molecular diagnostics: a prospective, randomized crossover trial.Translational cancer research · 2024Article
- Death by a thousand delays.JTCVS open · 2024Article
16 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLow-dose CT (LDCT) screening reduces lung cancer mortality by at least 20%. The COVID-19 pandemic required an unprecedented shutdown in our institutional LDCT program. The purpose of this study was to examine the impact of COVID-19 on lung cancer screening and subsequent cancer diagnosis. STUDY
designWe analyzed our prospective institutional LDCT screening database, which began in 2012. In all, 2,153 patients have participated. Monthly mean number of LDCTs were compared between baseline (January 2017 to February 2020) and COVID-19 periods (March 2020 to July 2020).
resultsLDCT was suspended on March 13, 2020 and 818 screening visits were cancelled. Phased reopening began on May 5, 2020 and full opening on June 1, 2020. Total monthly mean ± SD LDCTs (146 ± 31 vs 39 ± 40; p < 0.01) and new patient monthly LDCTs (56 ± 14 vs 15 ± 17; p < 0.01) were significantly decreased during the COVID-19 period. New patient monthly LDCTs have remained low despite resuming full operations. Three- and 6-month interval follow-up LDCTs were prioritized and were significantly increased compared with baseline (11 ± 4 vs 30 ± 4; p < 0.01). The "no-show" rate was significantly increased from baseline (15% vs 40%; p < 0.04). Most concerning, the percentage of patients with lung nodules suspicious for malignancy (Lung-RADS 4) were significantly increased after screenings resumed (8% vs 29%; p < 0.01).
conclusionsCOVID-19 caused significant disruption in lung cancer screening, leading to a decrease in new patients screened and an increased proportion of nodules suspicious for malignancy once screening resumed. Using lung cancer and the LDCT screening program as a model, this early analysis showed the unrecognized consequences related to the pandemic for screening programs and cancer care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.